A Study of Lumigan® in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Status:
Completed
Trial end date:
2010-11-01
Target enrollment:
Participant gender:
Summary
This is an observational study of Lumigan® 0.01% (bimatoprost) treatment in clinical practice
for patients with Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT).